Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

ESTRO-ACROP guideline: Interstitial multi-catheter breast brachytherapy as Accelerated Partial Breast Irradiation alone or as boost - GEC-ESTRO Breast Cancer Working Group practical recommendations.

Strnad V, Major T, Polgar C, Lotter M, Guinot JL, Gutierrez-Miguelez C, Galalae R, Van Limbergen E, Guix B, Niehoff P, Lössl K, Hannoun-Levi JM.

Radiother Oncol. 2018 Apr 21. pii: S0167-8140(18)30197-X. doi: 10.1016/j.radonc.2018.04.009. [Epub ahead of print]

2.

GEC-ESTRO ACROP recommendations in skin brachytherapy.

Guinot JL, Rembielak A, Perez-Calatayud J, Rodríguez-Villalba S, Skowronek J, Tagliaferri L, Guix B, Gonzalez-Perez V, Valentini V, Kovacs G; GEC ESTRO.

Radiother Oncol. 2018 Mar;126(3):377-385. doi: 10.1016/j.radonc.2018.01.013. Epub 2018 Feb 16.

3.

Infrastructure and equipment for radiation oncology in the Spanish National Health System: analysis of external beam radiotherapy 2015-2020.

Rodríguez A, Algara M, Monge D, López-Torrecilla J, Caballero F, Morera R, Escó R, Pérez-Montero H, Ferrer C, Lara PC; Spanish Society of Oncology and Radiotherapy (SEOR) Analysis Group.

Clin Transl Oncol. 2018 Mar;20(3):402-410. doi: 10.1007/s12094-017-1727-x. Epub 2017 Aug 3.

PMID:
28776310
4.

Recommendations from GEC ESTRO Breast Cancer Working Group (II): Target definition and target delineation for accelerated or boost partial breast irradiation using multicatheter interstitial brachytherapy after breast conserving open cavity surgery.

Major T, Gutiérrez C, Guix B, van Limbergen E, Strnad V, Polgár C; Breast Cancer Working Group of GEC-ESTRO.

Radiother Oncol. 2016 Jan;118(1):199-204. doi: 10.1016/j.radonc.2015.12.006. Epub 2016 Jan 8.

PMID:
26776444
5.

Interobserver variations of target volume delineation in multicatheter partial breast brachytherapy after open cavity surgery.

Major T, Gutiérrez C, Guix B, Mózsa E, Hannoun-Levi JM, Lössl K, Niehoff P, Resch A, van Limbergen E, Polgár C.

Brachytherapy. 2015 Nov-Dec;14(6):925-32. doi: 10.1016/j.brachy.2015.06.008. Epub 2015 Jul 21.

PMID:
26209477
6.

Estimating preferences for treatments in patients with localized prostate cancer.

Ávila M, Becerra V, Guedea F, Suárez JF, Fernandez P, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Sancho G, Cunillera O, Pardo Y, Cots F, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer.

Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):277-87. doi: 10.1016/j.ijrobp.2014.09.044. Epub 2014 Dec 6.

PMID:
25491504
7.

Obtaining Indirect Utilities with the Sf-6d and the Porpus-U in Prostate Cancer Patients.

Avila MM, Pardo Y, Castells M, Ferrer F, Boladeras A, Pera J, Prada P, Guix B, de Paula B, Hernandez H, Pont A, Alonso J, Garin O, Ferrer M.

Value Health. 2014 Nov;17(7):A646. doi: 10.1016/j.jval.2014.08.2342. Epub 2014 Oct 26. No abstract available.

8.

Salvage brachytherapy in prostate local recurrence after radiation therapy: predicting factors for control and toxicity.

Henríquez I, Sancho G, Hervás A, Guix B, Pera J, Gutierrez C, Abuchaibe O, Martínez-Monge R, Tormo A, Polo A.

Radiat Oncol. 2014 Apr 30;9:102. doi: 10.1186/1748-717X-9-102.

9.

Adaptation and validation of the Spanish version of the Patient-Oriented Prostate Utility Scale (PORPUS).

Avila M, Pardo Y, Castells M, Ferrer F, Boladeras A, Pera J, Prada PJ, Guix B, de Paula B, Hernandez H, Pont A, Alonso J, Garin O, Bremner K, Krahn M, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer.

Qual Life Res. 2014 Nov;23(9):2481-7. doi: 10.1007/s11136-014-0701-0. Epub 2014 May 1.

PMID:
24789667
10.

Quality of life impact of treatments for localized prostate cancer: cohort study with a 5 year follow-up.

Ferrer M, Guedea F, Suárez JF, de Paula B, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Sancho G, Boladeras A, Ayala A, Craven-Bratle J, Ávila M, Cunillera O, Pardo Y, Alonso J, Aguiló F; Clinically Localized Prostate Cancer.

Radiother Oncol. 2013 Aug;108(2):306-13. doi: 10.1016/j.radonc.2013.05.038. Epub 2013 Jul 9.

PMID:
23849168
11.

Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer.

Katz A, Ferrer M, Suárez JF; Multicentric Spanish Group of Clinically Localized Prostate Cancer.

Radiat Oncol. 2012 Nov 20;7:194. doi: 10.1186/1748-717X-7-194.

12.

[Cost comparison of three treatments for localized prostate cancer in Spain: radical prostatectomy, prostate brachytherapy and external 3D conformal radiotherapy].

Becerra Bachino V, Cots F, Guedea F, Pera J, Boladeras A, Aguiló F, Suárez JF, Gallo P, Murgui L, Pont A, Cunillera O, Pardo Y, Ferrer M; Grupo Multicéntrico Español de Cáncer de Próstata Organoconfinado.

Gac Sanit. 2011 Jan-Feb;25(1):35-43. doi: 10.1016/j.gaceta.2010.10.008. Spanish.

13.

Exeresis and brachytherapy as salvage treatment for local recurrence after conservative treatment for breast cancer: results of a ten-year pilot study.

Guix B, Lejárcegui JA, Tello JI, Zanón G, Henríquez I, Finestres F, Martínez A, Fernandez-Ibiza J, Quinzaños L, Palombo P, Encinas X, Guix I.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):804-10. doi: 10.1016/j.ijrobp.2009.08.009. Epub 2010 Jan 26.

PMID:
20106605
14.

Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.

Ferrer M, Suárez JF, Guedea F, Fernández P, Macías V, Mariño A, Hervas A, Herruzo I, Ortiz MJ, Villavicencio H, Craven-Bratle J, Garin O, Aguiló F; Multicentric Spanish Group of Clinically Localized Prostate Cancer.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):421-32. doi: 10.1016/j.ijrobp.2007.12.024. Epub 2008 Mar 5.

PMID:
18325680
15.

Treatment of keloids by high-dose-rate brachytherapy: A seven-year study.

Guix B, Henríquez I, Andrés A, Finestres F, Tello JI, Martínez A.

Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):167-72.

PMID:
11316560
16.

Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds.

Guix B, Finestres F, Tello J, Palma C, Martinez A, Guix J, Guix R.

Int J Radiat Oncol Biol Phys. 2000 Apr 1;47(1):95-102.

PMID:
10758310
17.

Lactation after conservative treatment for breast cancer.

Guix B, Tello JI, Finestres F, Palma C, Martínez A.

Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):515-6. Review. No abstract available.

PMID:
10661361
18.

Monte Carlo calculation of the dose distributions of two 106Ru eye applicators.

Sánchez-Reyes A, Tello JI, Guix B, Salvat F.

Radiother Oncol. 1998 Nov;49(2):191-6. Erratum in: Radiother Oncol 1999 Mar;50(3):373. Tello JJ [corrected to Tello JI].

PMID:
10052886
19.

[Lactation after the conservative treatment of breast cancer].

Guix B, Lejárcegui JA, García J, Sendra M.

Med Clin (Barc). 1991 Mar 16;96(10):399. Spanish. No abstract available.

PMID:
2046425
20.

Intraarterial infusion chemotherapy as a primary treatment in cancer of uterine cervix limited to the pelvis.

Lejarcegui JA, Cot X, Lailla JM, Tarrats A, Davi E, Ausin J, Marquez M, Jou P, Guix B, Gonzales-Merlo J, et al.

Eur J Gynaecol Oncol. 1988;9(5):403-9.

PMID:
2465157

Supplemental Content

Loading ...
Support Center